Microstructural white matter damage on MRI is associated with disease severity in Dutch-type cerebral amyloid angiopathy.

Cerebral amyloid angiopathy Dutch-type hereditary cerebral amyloid angiopathy MRI CAA-small vessel disease burden cognitive impairment diffusion magnetic resonance imaging

Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
17 Jun 2024
Historique:
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

Peak width of skeletonized mean diffusivity (PSMD) is an emerging diffusion-MRI based marker to study subtle early alterations to white matter microstructure. We assessed PSMD over the clinical continuum in Dutch-type hereditary CAA (D-CAA) and its association with other CAA-related MRI-markers and cognitive symptoms. We included (pre)symptomatic D-CAA mutation-carriers and calculated PSMD from diffusion-MRI data. Associations between PSMD-levels, cognitive performance and CAA-related MRI-markers were assessed with linear regression models. We included 59 participants (25/34 presymptomatic/symptomatic; mean age 39/58 y). PSMD-levels increased with disease severity and were higher in symptomatic D-CAA mutation-carriers (median [range] 4.90 [2.77-9.50]mm

Identifiants

pubmed: 38886875
doi: 10.1177/0271678X241261771
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271678X241261771

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: N. Vlegels reports support by the Netherlands CardioVascular Research Initiative–the Dutch Heart Foundation (CVON 2018–28 & 2012–06). M.R. Schipper reports independent support from the TRACK D-CAA consortium, consisting of Alnylam, Biogen, the Dutch CAA foundation, Vereniging HCHWA-D, and researchers from Leiden, Boston, and Perth. A. De Luca reports independent support from Alzheimer Nederland (WE-03-2022-11) as well as from ZonMW. R. van Dort is funded by the TRACK D-CAA consortium, consisting of Biogen, Alnylam, the Dutch CAA foundation, Vereniging HCHWA-D, and researchers from Leiden, Boston, and Perth. G.M. Terwindt reports independent support from the Dutch Research Council (NWO), European Community, the Dutch Heart Foundation, the Dutch Brain Foundation, and the Dutch CAA foundation.M.J.P. van Osch reports support by a NWO-VICI grant (016.160.351) and a NWO-Human Measurement Models 2.0 grant (18969) as well as support from the Dutch Research Council (NWO), European Community, the Dutch Heart Foundation, and the Dutch Brain Foundation.M.J.H. Wermer reports independent support from de Nederlandse Organisatie voor Wetenschappelijk Onderzoek ZonMw (VIDI grant 91717337), the Netherlands Heart Foundation, and the Dutch CAA foundation. The others report no conflicts.

Auteurs

Ingeborg Rasing (I)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Naomi Vlegels (N)

Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Manon R Schipper (MR)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Sabine Voigt (S)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Emma A Koemans (EA)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Kanishk Kaushik (K)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Rosemarie van Dort (R)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Thijs W van Harten (TW)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Alberto De Luca (A)

Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Ellis S van Etten (ES)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Erik W van Zwet (EW)

Department of Biostatistics, Leiden University Medical Center, Leiden, The Netherland.

Mark A van Buchem (MA)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Huub Am Middelkoop (HA)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Institute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.

Geert Jan Biessels (GJ)

Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Gisela M Terwindt (GM)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Matthias Jp van Osch (MJ)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Marianne Aa van Walderveen (MA)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Marieke Jh Wermer (MJ)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.

Classifications MeSH